Cargando…
Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)
Outbreaks of viral hemorrhagic fever caused by filoviruses have become more prevalent in recent years, with outbreaks of Ebola virus (EBOV), Sudan virus (SUDV), and Marburg virus (MARV) all occurring in 2022 and 2023. While licensed vaccines are now available for EBOV, vaccine candidates for SUDV an...
Autores principales: | Parish, Lindsay A., Stavale, Eric J., Houchens, Christopher R., Wolfe, Daniel N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301178/ https://www.ncbi.nlm.nih.gov/pubmed/37376509 http://dx.doi.org/10.3390/vaccines11061120 |
Ejemplares similares
-
A Call to Action to Enhance Filovirus Disease Outbreak Preparedness and Response
por: Roddy, Paul
Publicado: (2014) -
Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority
por: Bergmann, Julie N., et al.
Publicado: (2022) -
Selection of Filovirus Isolates for Vaccine Development Programs
por: Wolfe, Daniel N., et al.
Publicado: (2021) -
Filovirus Disease Outbreaks: A Chronological Overview
por: Languon, Sylvester, et al.
Publicado: (2019) -
Development and Structural Analysis of Antibody Therapeutics for Filoviruses
por: Yu, Xiaoying, et al.
Publicado: (2022)